REGENERON PHARMACEUTICALS, INC. reports

Company location: Tarrytown, NY
Fiscal year end: 31 December

REGENERON PHARMACEUTICALS, INC. has filed 2,462 SEC EDGAR filings since 26 Jul 1995

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 576-600 of 1,000 matching filings.

Per page

25

Current page

24

4

PRIMARY DOCUMENT

Filing date: 10 Dec 2021
Reporting date: 08 Dec 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 10 Dec 2021
Reporting date: 08 Dec 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 10 Dec 2021
Reporting date: 08 Dec 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 06 Dec 2021
Reporting date: 03 Dec 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 02 Dec 2021
Reporting date: 01 Dec 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 02 Dec 2021
Reporting date: 01 Dec 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 23 Nov 2021
Reporting date: 19 Nov 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 19 Nov 2021
Reporting date: 19 Nov 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 18 Nov 2021
Reporting date: 16 Nov 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 18 Nov 2021
Reporting date: 16 Nov 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 17 Nov 2021
Reporting date: 15 Nov 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 17 Nov 2021
Reporting date: 15 Nov 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

S-3ASR File 333-260763

S-3ASR

Filing date: 04 Nov 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 000-19034

10-Q

Filing date: 04 Nov 2021
Reporting date: 30 Sep 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 000-19034

8-K

Filing date: 04 Nov 2021
Reporting date: 04 Nov 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 03 Nov 2021
Reporting date: 01 Nov 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 03 Nov 2021
Reporting date: 01 Nov 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 04 Oct 2021
Reporting date: 01 Oct 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 04 Oct 2021
Reporting date: 01 Oct 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 17 Sep 2021
Reporting date: 15 Sep 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-19034

FORM 8-K

Filing date: 16 Sep 2021
Reporting date: 14 Sep 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 15 Sep 2021
Reporting date: 13 Sep 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 15 Sep 2021
Reporting date: 13 Sep 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 15 Sep 2021
Reporting date: 13 Sep 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 13 Sep 2021
Reporting date: 10 Sep 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .